Sonoma Pharmaceuticals, Inc.
SNOA- Exchange
- Nasdaq
- Industry
- Surgical & Medical Instruments & Apparatus
- SEC CIK
- 0001367083
No open-market purchases or sales by Sonoma Pharmaceuticals, Inc. insiders were filed in the last 90 days; 14 institutions reported holding it in 13F filings for Q2 2026, worth $136.3K in total; no superinvestor holds it.
Q2 2023 vs. Q1 2023
How the institutions holding Sonoma Pharmaceuticals, Inc. changed between Q1 2023 and Q2 2023.
All holders in Q2 2023All holders in Q1 2023
| Measure | Q1 2023 | Q2 2023 | Change |
|---|---|---|---|
| Holders | 18 | 16 | −2 |
| Shares | 146.7K | 161.9K | +15.2K (+10.4%) |
| Value | $143.5K | $175.0K | +$31.4K (+21.9%) |
New holders (2)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q2 2023 but not at the end of Q1 2023.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Two Sigma Securities, LLC | 52,042 | $55.7K | 0.00% |
| State Street Corp | 24,315 | $26.5K | 0.00% |
Sold out (4)
Institutions that held Sonoma Pharmaceuticals, Inc. at the end of Q1 2023 and filed for Q2 2023 without it.
| Institution | Shares, Q1 2023 | Value, Q1 2023 |
|---|---|---|
| Millennium Management LLC | 23,574 | $23.0K |
| Ground Swell Capital, LLC | 13,329 | $13.0K |
| Advisory Services Network, LLC | 2,463 | $2.40K |
| JPMorgan Chase & Co | 672 | $1.00K |